Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Burning Rock Biotech (BNR) Accumulated Depreciation & Amortization (2019 - 2025)

Burning Rock Biotech has reported Accumulated Depreciation & Amortization over the past 7 years, most recently at $3.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 57.78% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, down 57.78%, while the annual FY2025 figure was $3.1 million, 56.48% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $3.1 million at Burning Rock Biotech, down from $7.3 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $18.5 million in Q4 2023 and troughed at $3.1 million in Q4 2025.
  • A 5-year average of $10.8 million and a median of $7.5 million in 2021 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 133.55% in 2022 and later crashed 60.78% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $7.5 million in 2021, then surged by 133.55% to $17.4 million in 2022, then increased by 6.18% to $18.5 million in 2023, then crashed by 60.78% to $7.3 million in 2024, then crashed by 57.78% to $3.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BNR at $3.1 million in Q4 2025, $7.3 million in Q4 2024, and $18.5 million in Q4 2023.